Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies

Clinical trial NCT02531360 · COMPLETED

Trial details

NCT number: NCT02531360
Sponsor: Molecular NeuroImaging
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease (AD)Progressive Supranuclear Palsy (PSP)Cortical Basal Syndrome (CBS)Frontal Temporal Dementia (FTD)

Start date: 2015-05-01
Primary completion: 2016-07-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.